title: Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications.
abstract: In a recent article in Cell Reports, we described a novel mechanism for acquired resistance against new small-molecule antiangiogenic tyrosine-kinase inhibitors (TKIs). Vascular normalization-inducing TKIs block glycolysis and trigger a nutritional stress response in the tumor compartment that induces a (targetable) switch to mitochondrial metabolism. We discuss the implications for clinical/translational studies and suggest areas for future research.
authors.affiliation: Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center , Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Quintela-Fandino
keywords: Antiangiogenics; ME-344; breast cancer; metabolic synthetic lethality; nintedanib; phenformin; resistance